Denali Therapeutics Inc (DNLI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DNLI Annual Balance Sheets →
Balance sheet data covering Denali Therapeutics Inc–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent201.53
Marketable Securities, Current SH508.94
Cash & Short-term Investments709.00
Accounts receivable3.93
Inventories4.14
Prepaid Expense And Other Assets Current35.39
Total Current Assets753.93
Equipment/Property/Plant Net49.93
Intangible Assets35.25
Long-term investments232.63
Other Assets, Noncurrent86.22
Operating Lease Right Of Use Asset17.92
Total Assets1,157.96
Liabilities
Accounts Payable, Current AC11.81
Accrued Liabilities, Current AC78.28
Other Liabilities, Current0.00
Total Current Liabilities90.08
Total Long-term Debt0.00
Other liabilities, Noncurrent232.69
OperatingLeaseLiabilityNoncurrent24.68
Accrued Clinical And Other Research And Development Costs Current-
Other Accrued Manufacturing Costs Current-
Operating Lease Liability Current-
Total Liabilities322.78
Stockholders' Equity
Common Stock Value1.92
Additional Paid In Capital Common Stock3,142.75
Retained Earnings / Accumulated Deficit-2,307.52
Accumulated Other Comprehensive Income-1.97
Other Equity-1.97
Common Stockholder's Equity835.18
Total Stockholder's Equity835.18
Liabilities & Stockholder's Equity1,157.96
4 historic quarters locked

Sign in to unlock the full Denali Therapeutics Inc balance sheet history.

About Denali Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001714899-26-000097

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.